WA Centre for Health and Ageing,
Led by WACHA’s Professor Christopher Etherton-Beer, the OptiMed deprescribing study was a double-blind RCT in RACFs where two…
Led by WACHA’s Professor Christopher Etherton-Beer, the OptiMed deprescribing study was a double-blind RCT in RACFs where two…
The OptiMed deprescribing study was a double-blind RCT in RACFs where two pharmacists chose the medicines to target for…
Deprescribing in residential aged care could save between $1m and $16m annually if rolled out across Australia, according to…